Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liraglutide for Left Ventricular Function in Chronic Heart Failure with Type 2 Diabetes
NCT02650596Unknown
- Start
- Jan 2016
- Primary completion
- Feb 2018
- Modality
- Peptides
- Countries
- 1
01
Overview
Randomised, double-blind trial of liraglutide in heart failure (HF) (2 arms). Primary endpoint: Left Ventricular Ejection Fraction at 3 months. Status: unknown.
02
Drugs
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT02650596.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02650596.